Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 8, 1997

View Archived Issues

Cortecs: fiscal 1997 highlights

Clinical pharmacokinetics and safety described for YM-90K

Clinical pharmacokinetic profile of rhIL-10

Unique profile described for Glaxo Wellcome's 5alpha-reductase inhibitor

Potential early warning sign for heart transplant rejection

Cell Genesys reports development of second-generation lentiviral gene delivery system

FDA approves irbesartan for marketing

SB-207499: a second-generation PDE IV inhibitor from SmithKline Beecham

New discovery enhances feasibility of cardiovascular gene therapy

Hoechst describes Na+/H+-exchange inhibitors for ischemic disorders

Key cardiovascular gene therapy patent awarded to CardioGene Therapeutics

Agents for postmenopausal syndrome in development at Lilly

Antihyperlipidemic/antidiabetic agents reported by Otsuka

A-74259, an alpha-glucosidase inhibitor isolated from Streptomyces

Genetic basis of asthma becoming clearer, researchers report

New antiarrhythmics from American Cyanamid

Aastrom Biosciences awarded two NIH grants; begins phase I trial of UCB transplants

Breast cancer imaging agent approved in Canada

First approval for Infergen

ImmunoCyt introduced in Canada and Europe

Geref cleared for pediatric growth disorders in U.S.

GenVec/Parke-Davis collaboration focusing on angiogenic products

Idoxifene progresses to phase III for osteoporosis

Dermagraft launched in the U.K.

PowderJect and Boehringer Mannheim agreement for protein delivery

Synthelabo acquires German generics company

FDA grant awarded for research on Dupuytren's disease therapy

NIH evaluates St. John's wort for depression

Novel amphotericin B formulation reported by Japanese academics

FDA panel recommends approval of new uterine thermal ablation system

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...